Research & Foundation

Providing solutions for professionals working in reproductive medicine

+ 350 scientific publications

+ 6 patents

Collaborative projects with internationally renowned centers

17 laboratories worldwide

Overview

Research
Development

Research

The basis of our products lies in research intended to fulfill the needs of professionals and their patients.
All of the research projects performed at Igenomix are intended for clinical use.
Igenomix actively works in research and has organized and participated in a vast number of national and international talks and conferences.
The result of this hard work has led to the publication of an extensive array of peer reviewed articles.

Development

At Igenomix, we are involved in the full development process of diagnostic tests: from the original concept, undertaking clinical studies, producing and analysing results, to their transfer to become products available to the healthcare industry.
In the Products Development Department, we do not merely adapt already established procedures, but we innovate to provide our patients with the best services.
The staff at IGENOMIX actively works in research and employ the most advanced techniques applied to reproductive genetics.

Patents

Application number: PCT/ES2009/000386
Gene expression profile as an endometrial receptivity marker (ERA)
07/22/2009

Application number: PCT/US2015/021495
Early detection of preeclampsia
03/21/2014

Application number: PCT/IB2015/001715
Stem cell therapy in endometrial pathologies (Asherman)
06/17/2014

Application number: 62/554,471
Methods and devices for detecting biomarkers associated with preeclampsia
09/05/2017

Application number: 62/301,825
Non-Invasive Preimplantation Genetic Analysis and Related Methods (niPGS)
03/01/2016

Application number: 62/686,621
Methods, compositions and kits for assessing endometrial transformation
06/18/2018

Projects

Participation in competitive projects

Since its inception, Igenomix has actively worked to apply research to reproductive health. This effort is now being supported by several financial agencies through the projects indicated below.

IVACE, PROGRAMA CERTIFICA-CV. CERTIFICACIÓN DE I+D+i 2017. (Expd. IMACPA/2017/125, IMACPA/2017/116, MACPA/2017/124, IMACPA/2017/124, IMACPA/2017/123, IMACPA/2017/122, IMACPA/2017/120, IMACPA/2017/119, IMACPA/2017/117, IMACPA/2017/88). Cuantía concedida: 14.705,43 €
IVACE, PROGRAMA HORIZONTE-CV 2017. Expd. IMAPEA/2017/21. Cuantía concedida: 13.050 €
IVACE, PROGRAMA CERTIFICA-CV. CERTIFICACIÓN DE I+D+i 2016. (Expd. IMACPA/2016/263, IMACPA/2016/264, MACPA/2016/266, IMACPA/2016/269, IMACPA/2016/272, IMACPA/2016/274). Cuantía concedida: 16.950 €
IVACE, PROGRAMA AYUDAS PLAN INTERNACIONALIZACIÓN. ITAPIN IT16 PLANES DE INTERNACIONALIZACIÓN PYME CV. REF. ITAPIN/2016/459. Cuantía concedida: 21.076,12€ Plan Estratégico de internacionalización de la empresa IGENOMIX SL.
FP7 People Programme: Marie Curie Actions Marie Curie Industry-Academia Partnerships and Pathways (IAPP), 2013-2016. SARM 324509. Genómica endometrial y embrionaria. Búsqueda de biomarcadores en reproducción asistida.
EUREKA-EUROSTAR, 2011-2014. CIIP-20112001. Estudios no invasivos de disfunción endometrial – nuevas perspectivas clínicas para infertilidad y diagnóstico de la endometriosis.
MINECO, Programa TORRES QUEVEDO Convocatorias 2012, 2013, 2014, 2015 y 2016.

Request for Genetic counseling Session
Name*
Email*
Mobile
Country
User Type*
Service interested in*
Question
Please describe your current genetic condition*
Consentimiento*
Accept the privacy policy*

Igenomix is in the media

IGENOMIX has not affiliated any news outlet or publication identified above. News coverage does not constitute an endorsement of IGENOMIX or its products